Covered recipient · General Payments record
DONALD Y LEUNG
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2018–2024
$155,240.40
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,708.25 | 2 |
| Travel and Lodging | $588.60 | 2 |
| Food and Beverage | $119.65 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $12,318.57 | 5 |
| Johnson & Johnson Vision Care, Inc. | $69.07 | 3 |
| Amgen Inc. | $28.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $28.86 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117610247 | CMS |
| GENZYME CORPORATION | $8,912.25 | 03/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139680403 | CMS |
| GENZYME CORPORATION | $21.72 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139680405 | CMS |
| GENZYME CORPORATION | $169.47 | 03/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139680407 | CMS |
| GENZYME CORPORATION | $419.13 | 03/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139680409 | CMS |
| GENZYME CORPORATION | $2,796.00 | 12/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139680401 | CMS |
| Johnson & Johnson Vision Care, Inc. | $21.45 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077693611 | CMS |
| Johnson & Johnson Vision Care, Inc. | $27.68 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077693711 | CMS |
| Johnson & Johnson Vision Care, Inc. | $19.94 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077693653 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.